{"id":3935,"date":"2015-06-08T14:54:54","date_gmt":"2015-06-08T14:54:54","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/nyemissionen-i-nanexa-overtecknad\/"},"modified":"2015-06-08T14:54:54","modified_gmt":"2015-06-08T14:54:54","slug":"nyemissionen-i-nanexa-overtecknad","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nyemissionen-i-nanexa-overtecknad\/","title":{"rendered":"Nyemissionen i Nanexa \u00f6vertecknad"},"content":{"rendered":"
<\/strong><\/div>\n

Den 5 juni avslutades teckningstiden i Nanexa ABs listningsemission. Aktier f\u00f6r 65 miljoner kronor motsvarande en teckningsgrad om 630 % tecknades i emissionen av 1\u00a0304 tecknare. <\/span><\/p>\n

\u201dJag \u00e4r naturligtvis oerh\u00f6rt glad \u00f6ver det stora intresset f\u00f6r Nanexa AB och att vi har f\u00e5tt ett stort antal nya aktie\u00e4gare, som jag h\u00e4rmed vill h\u00e4lsa varmt v\u00e4lkomna. Tack vare emissionen kan vi nu accelerera produkt och aff\u00e4rsutveckling f\u00f6r att n\u00e5 utsatta m\u00e5l.\u201d, s\u00e4ger David Westberg, VD i Nanexa AB.<\/span><\/p>\n

I listningsemissionen har 1\u00a0150\u00a0000 aktier emitterats, vilket medf\u00f6r en h\u00f6jning av Nanexas aktiekapital med 148 835 kr. Nanexa AB tillf\u00f6rs i och med listningsemissionen 10,35 miljoner kronor f\u00f6re emissionskostnader vilka kommer att uppg\u00e5 till 1,1 miljoner kronor.<\/span><\/p>\n

Med anledning av den h\u00f6ga teckningsgraden kan full tilldelning ej ske. Tilldelning av aktier har beslutats av styrelsen i enlighet med fastst\u00e4llda och redovisade tilldelningsprinciper med fr\u00e4msta syfte att f\u00e5 en s\u00e5 bred \u00e4garbas som m\u00f6jligt.<\/span><\/p>\n

70% av emissionen var s\u00e4kerst\u00e4lld genom teckningsf\u00f6rbindelser uppg\u00e5ende till 18% samt garanti\u00e5taganden uppg\u00e5ende till 52% av emissionslikviden. Garantiavtalen som ingicks mellan den 5 \u2013 11 maj stipulerar att ers\u00e4ttningen till garanterna skall utg\u00f6ras av totalt 59 939 aktier emitterade till samma kurs som i listningsemissionen det vill s\u00e4ga 9 kr\/aktie. Denna information \u00e5terfinns inte i bolagets informationsmemorandum <\/span><\/p>\n

I syfte att bland annat ut\u00f6ka allm\u00e4nhetens tilldelning i listningsemissionen har styrelsen, med st\u00f6d av det bemyndigande som erh\u00f6lls av bolagsst\u00e4mman den 7 maj 2015, beslutat om en kvittningsemission om 59\u00a0939 aktier riktad till garanterna. <\/span><\/p>\n

Antalet aktier som emitteras i listningsemissionen samt kvittningsemissionen uppg\u00e5r totalt till 1\u00a0209\u00a0939, vilket medf\u00f6r en total h\u00f6jning av aktiekapitalet med 156\u00a0591,95 kr fr\u00e5n 500\u00a0000 kr till 656 591,95 kr.<\/span><\/p>\n

Avr\u00e4kningsnotor kommer att s\u00e4ndas ut idag den 8 juni med likviddag den 12 juni.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/p>\n

F\u00f6rsta dag f\u00f6r handel p\u00e5 AktieTorget har tidigarelagts fr\u00e5n den 24 juni till den 17 juni.<\/span><\/p>\n

Partner Fondkommission har varit finansiella r\u00e5dgivare i samband med erbjudandet.<\/span><\/p>\n

F\u00f6r mer information om erbjudandet kontakta:<\/span><\/p>\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
Telefon: 0709 -42 83 03
E-post:\u00a0<\/span>david<\/span>.westberg@nanexa.se<\/span><\/a><\/p>\n

Alt.<\/span><\/p>\n

Torben Oskarsson, Partner Fondkommission AB<\/span><\/p>\n

031-761 22 32, <\/span><\/p>\n

E-post: <\/span>torben.oskarsson@partnerfk.se<\/span><\/a><\/span><\/p>\n

www.nanexa.se<\/span><\/a><\/span><\/p>\n

Om Nanexa AB (publ)<\/span><\/p>\n

Nanexa AB \u00e4r ett h\u00f6gteknologiskt forskningsf\u00f6retag som utvecklar och marknadsf\u00f6r produkter inom nanoteknologi. Bolagets fokus ligger p\u00e5 PharmaShell\u00ae som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal omr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae har Nanexa samarbetsavtal med bland andra AstraZeneca och Karolinska Institutet.<\/span><\/span><\/strong><\/p>\n

\n

Bifogade filer<\/strong><\/p>\n\n

<\/a><\/p>\n<\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Den 5 juni avslutades teckningstiden i Nanexa ABs listningsemission. Aktier f\u00f6r 65 miljoner kronor motsvarande en teckningsgrad om 630 % tecknades i emissionen av 1\u00a0304 tecknare. <\/p>\n

\u201dJag \u00e4r naturligtvis oerh\u00f6rt glad \u00f6ver det stora intresset f\u00f6r Nanexa AB och att vi har f\u00e5tt ett stort antal nya aktie\u00e4gare,<\/p>\n

L\u00e4s mer<\/a><\/p>\n","protected":false},"template":"","class_list":["post-3935","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn-regulatory-listing_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-regulatory_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nNyemissionen i Nanexa \u00f6vertecknad - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nyemissionen-i-nanexa-overtecknad\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nyemissionen i Nanexa \u00f6vertecknad - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Den 5 juni avslutades teckningstiden i Nanexa ABs listningsemission. Aktier f\u00f6r 65 miljoner kronor motsvarande en teckningsgrad om 630 % tecknades i emissionen av 1\u00a0304 tecknare. \u201dJag \u00e4r naturligtvis oerh\u00f6rt glad \u00f6ver det stora intresset f\u00f6r Nanexa AB och att vi har f\u00e5tt ett stort antal nya aktie\u00e4gare,L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nyemissionen-i-nanexa-overtecknad\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nyemissionen-i-nanexa-overtecknad\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nyemissionen-i-nanexa-overtecknad\\\/\",\"name\":\"Nyemissionen i Nanexa \u00f6vertecknad - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2015-06-08T14:54:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nyemissionen-i-nanexa-overtecknad\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nyemissionen-i-nanexa-overtecknad\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nyemissionen-i-nanexa-overtecknad\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nyemissionen i Nanexa \u00f6vertecknad\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nyemissionen i Nanexa \u00f6vertecknad - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nyemissionen-i-nanexa-overtecknad\/","og_locale":"sv_SE","og_type":"article","og_title":"Nyemissionen i Nanexa \u00f6vertecknad - Nanexa AB","og_description":"Den 5 juni avslutades teckningstiden i Nanexa ABs listningsemission. Aktier f\u00f6r 65 miljoner kronor motsvarande en teckningsgrad om 630 % tecknades i emissionen av 1\u00a0304 tecknare. \u201dJag \u00e4r naturligtvis oerh\u00f6rt glad \u00f6ver det stora intresset f\u00f6r Nanexa AB och att vi har f\u00e5tt ett stort antal nya aktie\u00e4gare,L\u00e4s mer","og_url":"https:\/\/nanexa.com\/mfn_news\/nyemissionen-i-nanexa-overtecknad\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nyemissionen-i-nanexa-overtecknad\/","url":"https:\/\/nanexa.com\/mfn_news\/nyemissionen-i-nanexa-overtecknad\/","name":"Nyemissionen i Nanexa \u00f6vertecknad - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2015-06-08T14:54:54+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nyemissionen-i-nanexa-overtecknad\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nyemissionen-i-nanexa-overtecknad\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nyemissionen-i-nanexa-overtecknad\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nyemissionen i Nanexa \u00f6vertecknad"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}